Related Experiment Videos
HE2000 begins clinical trials: interview with James Frincke, Ph.D. Interview by John S. James
AIDS Treatment News
|May 22, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs.
Clinical and experimental immunology·2009
HE3286: a novel synthetic steroid as an oral treatment for autoimmune disease.
Annals of the New York Academy of Sciences·2009
A new orally bioavailable synthetic androstene inhibits collagen-induced arthritis in the mouse: androstene hormones as regulators of regulatory T cells.
Annals of the New York Academy of Sciences·2007
Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2006
Anti-inflammatory and immune regulatory properties of 5-androsten-3beta, 17beta-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases.
Annals of the New York Academy of Sciences·2005
Flu shot reminder.
AIDS treatment news·2008
AIDS search engine wanted: what to do now?
AIDS treatment news·2007
Is cure possible for HIV?
AIDS treatment news·2007
Financial accounts that can reproduce, inherit, and evolve.
AIDS treatment news·2007
Selling digital art in bulk through prepaid URLs.
AIDS treatment news·2007
Crocin as a multimodal therapy for multiple sclerosis: Recent breakthroughs in immunomodulation and neuroprotection.
Current journal of neurology·2026
SLC25A38 gene modification mediated by CRISPR/Cas9 in HEK293T cell line.
Journal of applied genetics·2026
Adipose-Derived Stem Cells in Ophthalmic Regenerative Medicine: From Cell Replacement to Precision Engineering.
Stem cell reviews and reports·2026
Application of Fibronectin-Coated Microparticles for Isolation of Human iPSC-Derived MSCs.
Tissue engineering and regenerative medicine·2026
Self-Amplifying RNA-Based Therapeutics: Advances, Challenges, and Future Perspectives.
Small (Weinheim an der Bergstrasse, Germany)·2026